SCHEMBL326200

SCHEMBL326200

C=CC(N)Oc1ccc(OCc2ccccc2)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 3/20 0.54
L3MBTL1 Q9Y468 2/20 0.54
GAA P10253 1/20 0.54
MAPT P10636 1/20 0.54
MAOA P21397 1/20 0.54
RAB9A P51151 1/20 0.54
SMN1; SMN2 Q16637 1/20 0.54
LMNA P02545 2/20 0.51
CYP1A2 P05177 1/20 0.51
PTGS1 P23219 1/20 0.51
SLC6A2 P23975 1/20 0.51
CYP2C19 P33261 1/20 0.51
PTGS2 P35354 1/20 0.51
SLC6A3 Q01959 1/20 0.51
HIF1A Q16665 1/20 0.51
HDAC6 Q9UBN7 1/20 0.51
LTA4H P09960 2/20 0.51
PPARG P37231 2/20 0.50
PPARA Q07869 2/20 0.50
PARP10 Q53GL7 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9464819 0.81 MAOB (0.54) MAOBL3MBTL1GAAMAPTMAOA
SCHEMBL527140 0.80 SCN4A (0.36) MAOALTA4HCA1CA2CA4
SCHEMBL11579600 0.78 MAOB (0.59) MAOBL3MBTL1GAAMAPTMAOA
SCHEMBL9501295 0.78 MAOA (0.47) MAOBMAOARAB9ALTA4HPPARG
SCHEMBL5574633 0.77 LMNA (0.55) MAOBL3MBTL1GAAMAPTMAOA
SCHEMBL339813 0.76 LMNA (0.82) MAOBL3MBTL1GAAMAPTMAOA
SCHEMBL27367676 0.76 LMNA (0.82) MAOBL3MBTL1GAAMAPTMAOA
SCHEMBL2169398 0.75 SLC1A3 (0.47) MAOBL3MBTL1GAAMAPTMAOA
SCHEMBL8147428 0.74 MRGPRX4 (0.63) MAOBL3MBTL1GAAMAPTMAOA
SCHEMBL8634028 0.74 LMNA (0.60) MAOBL3MBTL1GAAMAPTMAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130261178-A1 PHENOXYPROPANOL DERIVATIVES AND THEIR USE IN TREATING CARDIAC AND CARDIOVASCULAR DISEASES MISTRY SHAILESH (GB) 2013-10-03 US disclosed
EP-2590937-A1 PHENOXYPROPANOL DERIVATIVES AND THEIR USE IN TREATING CARDIAC AND CARDIOVASCULAR DISEASES The University Of Nottingham (GB) 2013-05-15 EP disclosed
WO-2012004549-A1 PHENOXYPROPANOL DERIVATIVES AND THEIR USE IN TREATING CARDIAC AND CARDIOVASCULAR DISEASES THE UNIVERSITY OF NOTTINGHAM (GB) 2012-01-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130261178-A1 PHENOXYPROPANOL DERIVATIVES AND THEIR USE IN TREATING CARDIAC AND CARDIOVASCULAR DISEASES NR3C2, NPR3, ADRB3 MAOB 1022/4885L3MBTL1 2940/4885GAA 4255/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.